A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis.
D000293:Adolescent; D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003165:Complement System Proteins / Q000032:analysis; D003404:Creatinine / Q000652:urine; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy; D007677:Kidney Function Tests; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011507:Proteinuria / Q000209:etiology; D013997:Time Factors
D000974:Antibodies, Antinuclear; D010919:Placebos; D003520:Cyclophosphamide; D003165:Complement System Proteins; D003404:Creatinine; D001379:Azathioprine